Researchers suggest their approach has the potential to transform early disease detection and health monitoring across diverse clinical settings.

Detection Market · GlobeNewswire Inc. The cell-free tumor DNA detection market is set to experience significant growth, ...

MethylScan is a new low-cost cell-free DNA methylome test that removes much of the healthy blood DNA background, helping rare ...

April 9, 2026 - By Denise Heady - UCLA scientists have developed a simple and cost-effective blood test that, in early ...

Revolutionary DNA test by BillionToOne could transform early cancer detection and prenatal screening in the US.

Scientists have developed a simple and cost-effective blood test that shows promise for detecting multiple cancers, various ...

Zymo Research, a global leader in life science technologies, and STORI, a new women's health company, today announced a ...

MethylScan is a low-cost blood test that detects multiple cancers and liver diseases by analyzing DNA methylation patterns ...

Stepping away from its billions-of-years-old role as a genetic blueprint, DNA is now embarking on a new journey as an active ...

Researchers developed a retron-based system that enables DNA to function as an active intracellular tool rather than merely ...